Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

rhIL-11 sees first launch

Feb. 17, 1998

SmithKline Beecham discovers nonpeptide G-CSF mimetics

Feb. 17, 1998

Micronized fenofibrate receives FDA approval

Feb. 16, 1998

Hypocholesterolemic agents disclosed by Warner-Lambert

Feb. 16, 1998

New antiobesity agent now being distributed in U.S.

Feb. 13, 1998

Pamidronate beneficial in multiple myeloma with bone complications

Feb. 13, 1998

Pharmacia & Upjohn reveals novel compounds and novel methods of treating NIDDM

Feb. 13, 1998

Sankyo researches new antidiabetic agents

Feb. 13, 1998

Goralatide: a candidate hematopoietic agent from Beaufour Ipsen

Feb. 12, 1998

Adenosine agonists with antilipolytic activity described by Glaxo

Feb. 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...